I25.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Elective cardiac srugery -- OPCAB only Age > 18 years Written informed consent Patients with or without type-2 diabetes and micro-/ macro-Albuminurea
Exclusion criteria
Exclusion criteria: Study withdrawal Recruitment in other clinical trial Personel of Jena university hospital or relatives Patients undergoing surgery with cardiopulmonary bypass
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study Endpoint: To analyze the effect of crystalloid fluid infusion on total body water and composition of the extracellular and intracellular space defined by central and peripheral edema. Catecholamine dependency and renal dysfunction will also be assessed. Measurement: - Bioimpedance Analysis to evaluate body water composition - blood samples to measure Glycocalyx - Lung ultrasound to measure central edema - skin wrinkels to measure peripheral edema - Hemodynamics with Pulse contour cardiac output Timepoint of measurement: - prior anaesthesia - immediately after surgery - on postoperative days 1 and 2 - prior discharge from Intensive care unit - prior hospital discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Association of total body fluid, hemodynamic and lung water content in the perioperative period 2. Measurement of Gykokalyxdysfunction 3. Expression of hormonactive peptides in the epicardial adipose tissue and blood plasma 4. Metabolomics in epicardial adipose tissue 5. To evaluate differences between patients with type-2 diabetes and patients without diabetes 6 To monitor the clinical outcome | — |
Countries
Germany
Contacts
Klinik für Anästhesiologie und IntensivmedizinUniversitätsklinikum Jena